Maternal Blood Test Market Size to Reach USD 10.12 Billion Globally with Growing CAGR of 13.00% by 2030
Global Maternal Blood Test Market research report has been produced with a nice blend of industry insight, smart and practical solutions and newest technology to endow with the better user experience. To execute market research study competent and advanced tools and techniques including SWOT analysis and Porter’s Five Forces Analysis have been employed. Besides, the market share of major competitors on global level is also studied where key areas such as Europe, North America, Asia Pacific and South America are taken into account in the persuasive Global Maternal Blood Test Market report. It simplifies the flow of information for better user understanding.
One of the major factors driving the growth of the maternal blood test market is the continuous improvement in the reimbursement scenario for NIPT around the world. An increase in the incidence of chromosomal abnormalities, combined with increasing product usage in new applications, drive market growth. The growing preference for non-invasive techniques over invasive methods, as well as an increase in programmes aimed at raising NIPT awareness, all have an impact on the market.
Data Bridge Market Research analyses that the maternal blood test market which was USD 3.807 billion in 2022, is expected to reach USD 10.12 billion by 2030, at a CAGR of 13.00% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-maternal-blood-test-market&Shri
Market Overview:
A maternal blood test is a type of prenatal screening test that determines the likelihood that a chromosome disorder will impact a pregnancy or certain behavioural issues will impact a pregnancy. The primary goal of the test is to ensure that the baby does not have any chromosomal abnormalities such as Down syndrome. These tests are known to be capable of providing more information about pregnancy health.
Drivers
- Rising use of maternal blood tests
Maternal blood tests can detect and diagnose chromosomal rearrangements, X-linked diseases, and aid in the reduction of spontaneous abortions, increased implantation rates, the prevention of trisomic offspring, and the avoidance of the risk of transmitting single gene disorders. However, PGS and PGD results are not 100% accurate, and if necessary, diagnostic tests such as amniocentesis and CVS must be performed after pregnancy to confirm the positive PGS/PGD results. In the United States alone, more than 63,000 babies were born through IVF in 2013, an increase of 2,000 births from 2012. These are the certain test that help the market to grow.
Opportunities
- Introduction of NIPTs
The introduction of NIPTs using cell-free foetal DNA (cffDNA) in 2011 was the most significant advancement in the field of prenatal screening. Obstetricians and patients who are put off by ultrasound screening’s 10% to 15% false positive rate and maternal serum test’s 5% false positive rate are eagerly embracing NIPTs that claim to have only a 5% false positive rate. In just four years, molecular genetics companies have successfully developed eight different types of kits for detecting genetic abnormalities in foetus. These products have gradually marginalized maternal serum tests, and maternal serum tests are expected to become obsolete within the next decade.
Fundamental Aim of this Market Report
- Factors influencing This Market Size and growth rate.
- Major alterations to this market in the near future.
- Notable Market rivals around the world.
- Future Scope and Product Outlook
- Future-promising emerging markets.
- The Market Presents Difficult Challenges and Threats.
Some of the major players operating in the maternal blood test market are:
- CENTOGENE N.V. (Germany)
- SEQUENOM (U.S.)
- Natera, Inc. (U.S.)
- LifeLabs Genetics (Canada)
- Sema4 OpCo, Inc. (U.S.)
- Invitae Corporation (U.S.)
- Illumina, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- General Electric (U.S.)
- PerkinElmer Inc. (U.S.)
- Agilent Technologies, Inc. (U.S.)
- BGI (China)
- F. Hoffmann-La Roche Ltd (Switzerland)
- YOURGENE HEALTH (U.K.)
- Eurofins Scientific (Luxembourg)
- EKF Diagnostics (Germany)
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-maternal-blood-test-market?Shri
Maternal Blood Test Market Scope
Type
- Combined First Trimester Screening
- Second Trimester Maternal Serum Screening
Tested Conditions
- Edwards Syndrome
- Patau Syndrome
- Down syndrome
- Neural Tube Defects
End-User
- Diagnostic Laboratories
- Hospitals
Key highlights of this Market report:
- Growth rate
- Remuneration prediction
- Consumption graph
- Market concentration ratio
- Secondary industry competitors
- Competitive structure
- Major restraints
- Market drivers
- Regional bifurcation
- Competitive hierarchy
- Current market tendencies
- Market concentration analysis
What benefits does the DBMR study is going to provide?
- Latest industry influencing trends and development scenario
- Open up New Markets
- To Seize powerful market opportunities
- Key decision in planning and to further expand market share
- Identify Key Business Segments, Market proposition & Gap Analysis
- Assisting in allocating marketing investments
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Market Regulations
- Market Overview
Continued…
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-maternal-blood-test-market&Shri
Key Benefits of the Report:
- This study presents the analytical depiction of this industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of this market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed this industry analysis based on competitive intensity and how the competition will take shape in the coming years.
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
